呼吸器感染症に対するAC-1370の効果

高木 健三; 山木 健市; 鈴木 隆二郎; 山川 育夫; 原 通広; 佐竹 辰夫; 横山 繁樹; 近藤 泰三; 田野 正夫

doi:10.11250/chemotherapy1953.32.Supplement9_337

AC-1370 TREATMENT OF PATIENTS WITH RESPIRATORY TRACT INFECTION

KENZO TAKAGI, KENICHI YAMAKI, RYUJIRO SUZUKI, IKUO YAMAKAWA, MICHIHIRO HARA, TATSUO SATAKE, SHIGEKI YOKOYAMA, TAIZO KONDO, MASAO TANO

Author information

KENZO TAKAGI
Second Department of Internal Medicine, Nagoya University, School of Medicine
KENICHI YAMAKI
Second Department of Internal Medicine, Nagoya University, School of Medicine
RYUJIRO SUZUKI
Second Department of Internal Medicine, Nagoya University, School of Medicine
IKUO YAMAKAWA
Second Department of Internal Medicine, Nagoya University, School of Medicine
MICHIHIRO HARA
Second Department of Internal Medicine, Nagoya University, School of Medicine
TATSUO SATAKE
Second Department of Internal Medicine, Nagoya University, School of Medicine
SHIGEKI YOKOYAMA
Department of Internal Medicine, Tosei Hospital
TAIZO KONDO
Department of Internal Medicine, Tosei Hospital
MASAO TANO
Department of Internal Medicine, Kariya General Hospital

JOURNAL FREE ACCESS

1984 Volume 32 Issue Supplement9 Pages 337-342

DOI https://doi.org/10.11250/chemotherapy1953.32.Supplement9_337

Details

Abstract

AC-1370 was administered to 20 patients with respiratory tract infection. The drug was administered by D. I. injection twice a day with the dosis of 1 to 2g and total dosis ranged from 12 to 40g.
The following results were obtained.
1) Clinical response to the therapy was excellent in 3 cases, good in 11 cases, fair in 4 cases and poor in 2 cases. Effective rate was 70.0%.
2) As for side effects, the elevation of GOT and GPT was found in 2 cases, but it was transient.

Corresponding author

Register with J-STAGE for free!